Evidence map›Paper›PMID 24131530›Full record

ReviewOrphanet journal of rare diseases2013

The expanding spectrum of rare monogenic autoinflammatory diseases.

Isabelle Touitou, Caroline Galeotti, Linda Rossi-Semerano, Véronique Hentgen, Maryam Piram, Isabelle Koné-Paut, CeRéMAI, French reference center for autoinflammatory diseases

Open access · goldAbstract readReview
In one paragraph

Review in Orphanet journal of rare diseases, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Isabelle TouitouLaboratoire de génétique des maladies rares et auto-inflammatoires, CHRU de Montpellier, Montpellier, France. isabelle.touitou@inserm.fr.
Caroline Galeotti
Linda Rossi-Semerano
Véronique Hentgen
Maryam Piram
Isabelle Koné-Paut
CeRéMAI, French reference center for autoinflammatory diseases
Bicêtre Hospital · FRAssistance Publique – Hôpitaux de Paris · FRCentre Hospitalier de Versailles · FRInstitut de Génétique Moléculaire de Montpellier · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Monogenic autoinflammatory diseases are a group of hereditary disorders characterized by a clinical and biological inflammatory syndrome in which there is little or no evidence of autoimmunity. The discovery of the first causative gene in 1997 was rapidly followed by the identification of many others from the same group. The mutated proteins can be directly or indirectly involved in the regulation of inflammation. The available literature includes numerous reviews, which address the principle diseases, but we wanted to focus on the most recent rare syndromes. A comprehensive review is thus provided, including taxonomic, genetic, and epidemiological data, along with characteristics defining positive and differential diagnoses and treatment. We believe that this update will assist physicians in correctly naming their patient's illness. This is an essential step for the effective and targeted management of an orphan disease.

Indexed as

Autoimmune DiseasesDiagnosis, DifferentialHumansRare Diseases

Identifiers

PMID24131530
PMCPMC4016572
OpenAlexW2143728162

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.